View By:
May 11 – 12
Therapeutic Interventions for COVID-19
Improving Immunotherapy Efficacy and Safety
Characterization for Novel Biotherapeutics
Difficult-to-Express Proteins
Display of Biologics
Antibodies for Cancer Therapy
Advancing Bispecific Antibodies and Combination Therapy to the Clinic
May 12 – 13
Driving Clinical Success in Antibody-Drug Conjugates
Accelerating Vaccine Development for COVID-19
CAR T, TCRs and TILS
Biophysical Methods
Engineering Antibodies
Optimizing Protein Expression
Engineering Bispecific Antibodies